PVA.AX : Summary for PSIVIDACOR CDI - Yahoo Finance

U.S. Markets closed

pSivida Corp. (PVA.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
2.340.00 (0.00%)
At close: 2:31PM AEDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close2.34
Bid2.18 x
Ask2.71 x
Day's Range2.34 - 2.34
52 Week Range2.10 - 5.25
Avg. Volume662
Market Cap81.15M
PE Ratio (TTM)-4.26
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • pSivida Corp. :PVA-AU: Earnings Analysis: Q2, 2017 By the Numbers : February 21, 2017
    Capital Cube4 days ago

    pSivida Corp. :PVA-AU: Earnings Analysis: Q2, 2017 By the Numbers : February 21, 2017

    Categories: Yahoo Finance Get free summary analysis pSivida Corp. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of AUD 7.97 million, Net Earnings of AUD -0.09 million. Change in operating cash flow of -46.92% compared to same period last year is about the same as change in earnings, likely no significant movement ... Read more (Read more...)

  • GlobeNewswire14 days ago

    pSivida to Present at the 2017 BIO CEO & Investor Conference

    WATERTOWN, Mass., Feb. 10, 2017-- pSivida Corp., a leader in the development of sustained release drug products, announced today that Nancy Lurker, President and Chief Executive Officer, is scheduled to ...

  • Associated Press17 days ago

    PSivida posts 2Q loss

    On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of less than 1 cent. The drug delivery technology company posted revenue of $6 million in the period. In the final minutes ...